| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |